These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23342261)

  • 1. Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations.
    Wong NK; Fuller M; Sung S; Wong F; Karsan A
    Cancer Med; 2012 Oct; 1(2):105-13. PubMed ID: 23342261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.
    Azzam DJ; Zhao D; Sun J; Minn AJ; Ranganathan P; Drews-Elger K; Han X; Picon-Ruiz M; Gilbert CA; Wander SA; Capobianco AJ; El-Ashry D; Slingerland JM
    EMBO Mol Med; 2013 Oct; 5(10):1502-22. PubMed ID: 23982961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
    Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
    Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.
    D'Angelo RC; Ouzounova M; Davis A; Choi D; Tchuenkam SM; Kim G; Luther T; Quraishi AA; Senbabaoglu Y; Conley SJ; Clouthier SG; Hassan KA; Wicha MS; Korkaya H
    Mol Cancer Ther; 2015 Mar; 14(3):779-787. PubMed ID: 25673823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
    Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.
    Harrison H; Farnie G; Howell SJ; Rock RE; Stylianou S; Brennan KR; Bundred NJ; Clarke RB
    Cancer Res; 2010 Jan; 70(2):709-18. PubMed ID: 20068161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary stem cells and breast cancer--role of Notch signalling.
    Farnie G; Clarke RB
    Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
    Chen J; Chang H; Peng X; Gu Y; Yi L; Zhang Q; Zhu J; Mi M
    Sci Rep; 2016 Jun; 6():28858. PubMed ID: 27345219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.
    Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Rafii S; Rafii A
    PLoS One; 2014; 9(11):e112424. PubMed ID: 25380486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
    Phillips TM; McBride WH; Pajonk F
    J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
    Vesuna F; Lisok A; Kimble B; Raman V
    Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial Notch signaling is a limiting step for pancreatic carcinogenesis.
    Thomas MM; Zhang Y; Mathew E; Kane KT; Maillard I; Pasca di Magliano M
    BMC Cancer; 2014 Nov; 14():862. PubMed ID: 25416148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.
    Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Halabi N; Guerrouahen BS; Rafii S; Rafii A
    J Transl Med; 2015 Jan; 13():27. PubMed ID: 25623554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
    Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
    J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence evasion by MCF-7 human breast tumor-initiating cells.
    Karimi-Busheri F; Rasouli-Nia A; Mackey JR; Weinfeld M
    Breast Cancer Res; 2010; 12(3):R31. PubMed ID: 20525204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
    Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
    Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.